Latest News and Press Releases
Want to stay updated on the latest news?
-
HAYWARD, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel...
-
CIP Real Estate acquired four industrial parks in Atlanta, Phoenix and Carlsbad, Calif., in December 2024.
-
SALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor enthusiast markets, today announced that...
-
Alameda Health System (AHS) is the recipient of a Quality Leaders Award for excellence in pediatric primary care.
-
HAYWARD, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel...
-
SANTA CLARA, CA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- With a bias for action and a track record of year-over-year success at technology and SaaS companies, Howard Doherty will now apply his deep...
-
C-Hawk Technology introduces Roberto™, the industry's first integrated robotics platform for plastic welding in semiconductor equipment manufacturing.
-
CAPE TOWN, South Africa, Nov. 18, 2024 (GLOBE NEWSWIRE) -- PrimeXBT, a leading multi-asset trading platform, is pleased to announce that it has secured a regulatory license from the Financial Sector...
-
LOS ANGELES, CA, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Grant Johnson, a results-driven marketing executive with an impressive track record, will now apply his extensive SaaS industry experience to...
-
-Positive 270-day Interim Clinical Study Data for the First Subject and Positive 180-day Interim Clinical Study Data for the Second Subject Treated with the Low-Dose of BB-301 in the Phase 1b/2a...